Eagle,
the part of the announcement that caught my attention related to the tax paid by the company for the 2023 financial year & the 2024 financial year of circa $AUD 89 million.
This will be a nice boost to Neuren’s Franking account. With all the cash flowing into the coffers it would be nice to see the company declare a fully franked dividend after provisioning for phase 3 trial costs
- Forums
- ASX - By Stock
- NEU
- Ann: 2024 results - A$166m comprehensive income for shareholders
NEU
neuren pharmaceuticals limited
Add to My Watchlist
0.32%
!
$12.50

Ann: 2024 results - A$166m comprehensive income for shareholders, page-24
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$12.50 |
Change
-0.040(0.32%) |
Mkt cap ! $1.548B |
Open | High | Low | Value | Volume |
$12.61 | $12.68 | $12.32 | $4.631M | 371.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 1051 | $12.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$12.50 | 2895 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 529 | 12.490 |
21 | 1090 | 12.480 |
3 | 647 | 12.470 |
6 | 1498 | 12.460 |
6 | 1576 | 12.450 |
Price($) | Vol. | No. |
---|---|---|
12.500 | 2939 | 9 |
12.510 | 3544 | 7 |
12.520 | 1661 | 6 |
12.530 | 1924 | 6 |
12.540 | 2529 | 9 |
Last trade - 14.43pm 25/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |